Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Sep 22;112(38):E5308-17.
doi: 10.1073/pnas.1514475112. Epub 2015 Aug 31.

Evidence for α-synuclein prions causing multiple system atrophy in humans with parkinsonism

Stanley B Prusiner  1 , Amanda L Woerman  2 , Daniel A Mordes  3 , Joel C Watts  4 , Ryan Rampersaud  2 , David B Berry  2 , Smita Patel  2 , Abby Oehler  5 , Jennifer K Lowe  6 , Stephanie N Kravitz  6 , Daniel H Geschwind  7 , David V Glidden  8 , Glenda M Halliday  9 , Lefkos T Middleton  10 , Steve M Gentleman  11 , Lea T Grinberg  12 , Kurt Giles  4
Affiliations

Evidence for α-synuclein prions causing multiple system atrophy in humans with parkinsonism

Stanley B Prusiner et al. Proc Natl Acad Sci U S A. .

Erratum in

Abstract

Prions are proteins that adopt alternative conformations that become self-propagating; the PrP(Sc) prion causes the rare human disorder Creutzfeldt-Jakob disease (CJD). We report here that multiple system atrophy (MSA) is caused by a different human prion composed of the α-synuclein protein. MSA is a slowly evolving disorder characterized by progressive loss of autonomic nervous system function and often signs of parkinsonism; the neuropathological hallmark of MSA is glial cytoplasmic inclusions consisting of filaments of α-synuclein. To determine whether human α-synuclein forms prions, we examined 14 human brain homogenates for transmission to cultured human embryonic kidney (HEK) cells expressing full-length, mutant human α-synuclein fused to yellow fluorescent protein (α-syn140*A53T-YFP) and TgM83(+/-) mice expressing α-synuclein (A53T). The TgM83(+/-) mice that were hemizygous for the mutant transgene did not develop spontaneous illness; in contrast, the TgM83(+/+) mice that were homozygous developed neurological dysfunction. Brain extracts from 14 MSA cases all transmitted neurodegeneration to TgM83(+/-) mice after incubation periods of ∼120 d, which was accompanied by deposition of α-synuclein within neuronal cell bodies and axons. All of the MSA extracts also induced aggregation of α-syn*A53T-YFP in cultured cells, whereas none of six Parkinson's disease (PD) extracts or a control sample did so. Our findings argue that MSA is caused by a unique strain of α-synuclein prions, which is different from the putative prions causing PD and from those causing spontaneous neurodegeneration in TgM83(+/+) mice. Remarkably, α-synuclein is the first new human prion to be identified, to our knowledge, since the discovery a half century ago that CJD was transmissible.

Keywords: Parkinson's disease; neurodegeneration; strains; synucleinopathies.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Fig. 1.
Fig. 1.
Neuropathological and biochemical analysis of synucleinopathy cases. (A) Gross pathology of one representative sample (MSA10) demonstrating depigmentation of the substantia nigra compared with nondiseased control. (B) Immunohistochemical detection of α-synuclein deposits in patient samples. Two representative PD samples and four representative MSA samples were stained for α-synuclein using the antibodies clone 42 (BD Biosciences; PD1, PD6, MSA1, MSA7, MSA10) and LB509 (MSA12). Arrowheads point to Lewy bodies, arrows to GCIs. (Scale bar, 50 µm for all samples.) (C) Immunoblots of brain homogenates of human control (C1), PD, and MSA cases show total human α-synuclein (Top) and detergent-insoluble phosphorylated α-synuclein (Middle). The brain region used for each case is noted: FC (frontal cortex), SN (substantia nigra), BG (basal ganglia), and P (pons). Blots were probed for actin as a loading control (Bottom). Total human α-synuclein was probed using the monoclonal antibody Syn211, and S129-specific, phosphorylated α-synuclein was probed with antibody EP1536Y. Molecular weight markers of migrated protein standards are shown in kilodaltons.
Fig. 2.
Fig. 2.
A cell infectivity assay can quantify infectivity in synucleinopathy tissue samples. (A) Representative images of α-syn140*A53T–YFP–expressing cells infected with PTA-precipitated brain homogenate from control (C1), PD, or MSA patients. YFP is shown in green. (Scale bars, 100 µm.) (B) Box and whisker plot of cell infectivity from PD and MSA samples shows a significant difference between the two groups (P < 0.001). Whiskers indicate maximum and minimum values. (C) For each of the MSA samples tested in both cell assay and mouse bioassay, cell infectivity and incubation time were significantly inversely correlated (R2 = 0.27, P = 0.026).
Fig. 3.
Fig. 3.
Inoculation of α-synuclein aggregates from MSA but not PD cases induced deposition of phosphorylated α-synuclein and reactive astrogliosis. (A) Brain homogenates were prepared from control (C1), PD, and MSA patients and IC inoculated into TgM83+/− mice. Mice inoculated with MSA homogenates, but not PD or control homogenates, showed deposition of phosphorylated α-synuclein in the brainstem (top panels, staining with EP1536Y antibody); Insets show a 4× magnification relative to the main image. These mice also showed prominent reactive astrogliosis, as indicated by GFAP staining (bottom panels). (Scale bars, 50 μm.) (B) Representative immunoblot shows total α-synuclein (Top) and detergent-insoluble phosphorylated α-synuclein (Middle) in the brains of TgM83+/− mice inoculated with homogenates from C1, PD, or MSA patients. The brain region for each inoculum is noted: FC (frontal cortex), P (pons), and SN (substantia nigra). Total α-synuclein was detected from the crude brain homogenates using the Syn211 antibody; phosphorylated α-synuclein was probed with the EP1536Y antibody. Actin is shown as a loading control (Bottom). Molecular weight markers of migrated protein standards are shown in kilodaltons. (C) Phosphorylated α-synuclein in the brains of TgM83+/− mice inoculated with PD or MSA was quantified by densitometry and expressed as an x-fold difference compared with mice inoculated with nondiseased control brain (C1). The brain-region origin for each inoculum is noted: BG (basal ganglia), FC (frontal cortex), P (pons), and SN (substantia nigra). For each inoculum, data from two animals are shown, except for the MSA11 inoculum, for which only one animal was available for biochemical analysis.
Fig. S1.
Fig. S1.
Distribution of phosphorylated α-synuclein deposition in the brains of TgM83+/− mice inoculated with control, PD, and MSA cases. Immunostaining for phosphorylated α-synuclein using antibody EP1536Y was performed in the brains of TgM83+/− mice inoculated with homogenate prepared from a nondiseased control brain (360 d after inoculation), a PD case (360 d after inoculation), and two MSA cases (90 and 109 d after inoculation). Several brain regions were assessed for the deposition of phosphorylated α-synuclein, which was only found following inoculation with MSA homogenates. (Scale bars, 50 µm.)
See this image and copyright information in PMC

Comment in

  • Expanding the prion disease repertoire.
    Supattapone S. Supattapone S. Proc Natl Acad Sci U S A. 2015 Sep 22;112(38):11748-9. doi: 10.1073/pnas.1515143112. Epub 2015 Sep 1. Proc Natl Acad Sci U S A. 2015. PMID: 26330608 Free PMC article. No abstract available.
  • Is Multiple System Atrophy a New Prion Disorder?
    Heras-Garvin A, Wenning GK. Heras-Garvin A, et al. Mov Disord. 2016 Mar;31(3):300. doi: 10.1002/mds.26537. Epub 2016 Feb 1. Mov Disord. 2016. PMID: 26833797 No abstract available.

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Gajdusek DC, Gibbs CJ, Jr, Alpers M. Experimental transmission of a Kuru-like syndrome to chimpanzees. Nature. 1966;209(5025):794–796. - PubMed
    1. Gibbs CJ, Jr, Gajdusek DC. An update on long-term in vivo and in vitro studies designed to identify a virus as the cause of amyotrophic lateral sclerosis, parkinsonism dementia, and Parkinson’s disease. Adv Neurol. 1982;36:343–353. - PubMed
    1. Graham JG, Oppenheimer DR. Orthostatic hypotension and nicotine sensitivity in a case of multiple system atrophy. J Neurol Neurosurg Psychiatry. 1969;32(1):28–34. - PMC - PubMed
    1. Papp MI, Kahn JE, Lantos PL. Glial cytoplasmic inclusions in the CNS of patients with multiple system atrophy (striatonigral degeneration, olivopontocerebellar atrophy and Shy-Drager syndrome) J Neurol Sci. 1989;94(1-3):79–100. - PubMed
    1. Spillantini MG, et al. Filamentous α-synuclein inclusions link multiple system atrophy with Parkinson’s disease and dementia with Lewy bodies. Neurosci Lett. 1998;251(3):205–208. - PubMed

Publication types

MeSH terms